WallStSmart
CMPX

Compass Therapeutics Inc.

NASDAQ: CMPX · HEALTHCARE · BIOTECHNOLOGY

$1.77
+5.99% today

Updated 2026-04-30

Market cap
$300.75M
P/E ratio
P/S ratio
269.28x
EPS (TTM)
$-0.42
Dividend yield
52W range
$2 – $7
Volume
6.9M

Compass Therapeutics Inc. (CMPX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+6.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+18.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+7.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+17.4%
2025-08-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-27$-0.09+5.7%$5.78$5.68-1.7%
2025-11-05$-0.08+44.1%$3.79$4.00+5.5%
2025-08-11$-0.14-16.7%$2.70$3.17+17.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.10$-0.09+5.7%
2025-09-30$-0.14$-0.08+44.1%
2025-06-30$-0.12$-0.14-16.7%
2025-03-31$-0.11$-0.12-9.1%
2024-12-31$-0.10$-0.11-10.0%
2024-09-30$-0.11$-0.08+27.3%
2024-06-30$-0.10$-0.10+0.0%$850000.00
2024-03-31$-0.11$-0.08+27.3%
2023-12-31$-0.09$-0.11-22.2%$2.84M
2023-09-30$-0.11$-0.08+27.3%
2023-06-30$-0.08$-0.09-12.5%

Frequently asked questions

Has Compass Therapeutics Inc. beaten earnings estimates?
Compass Therapeutics Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +6.0% over the last 4 quarters.
How does CMPX stock react to earnings?
CMPX stock has moved an average of +7.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.